Related Organization(s)

You just read:

Bausch + Lomb and Nicox Announce FDA Acceptance of New Drug Application for Novel Glaucoma Candidate VESNEO™ (latanoprostene bunod)

News provided by

Valeant Pharmaceuticals International, Inc.

Sep 22, 2015, 01:30 ET